T. Rowe Price Investment Management, Inc. Abb Vie Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 4,667,205 shares of ABBV stock, worth $840 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
4,667,205
Previous 4,825,713
3.28%
Holding current value
$840 Million
Previous $828 Million
11.35%
% of portfolio
0.56%
Previous 0.52%
Shares
8 transactions
Others Institutions Holding ABBV
# of Institutions
3,853Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$30.9 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$24.6 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$14.2 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$9.38 Billion0.84% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.97 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $318B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...